SOPHiA Genetics (SOPH) EPS (2020 - 2026)
SOPHiA Genetics (SOPH) EPS from Mar 31, 2020 to Mar 31, 2026. The TTM SOPHiA Genetics (SOPH) EPS is -$1.18. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
SOPHiA Genetics (SOPH) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +18.27% |
| 3 Years TTM | -2.46% |
| 5 Years TTM | +6.46% |
| All Time TTM | +6.46% |
Annual EPS change of SOPHiA Genetics (SOPH)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.27 | -76.78% |
| 2025 | -$1.17 | +23.13% |
| 2024 | -$0.95 | -22.12% |
| 2023 | -$1.22 | -10.59% |
| 2022 | -$1.36 | +2.41% |
| 2021 | -$1.33 | +62.61% |
| 2020 | -$0.82 | +54.83% |
| 2019 | -$0.53 | N/A |
Comparison SOPHiA Genetics (SOPH) five years EPS CAGR with competitors
SOPHiA Genetics (SOPH) five years EPS CAGR is 6.46%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| HQY | Healthequity Inc | 84.70% | +1211.37% |
| DOCS | Doximity Inc - Class A | 26.71% | +313.51% |
| VEEV | Veeva Systems Inc - Class A | 24.84% | +284.60% |
| EVH | Evolent Health Inc - Class A | 12.23% | +89.34% |
| HSTM | Healthstream Inc | 5.05% | -21.87% |
| HCAT | Health Catalyst Inc | 4.23% | -34.44% |